Pallotto, C.; Tommasi, A.; Svizzeretto, E.; Genga, G.; Gamboni, G.; Gidari, A.; Francisci, D.
Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes. Infect. Dis. Rep. 2024, 16, 828-835.
https://doi.org/10.3390/idr16050064
AMA Style
Pallotto C, Tommasi A, Svizzeretto E, Genga G, Gamboni G, Gidari A, Francisci D.
Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes. Infectious Disease Reports. 2024; 16(5):828-835.
https://doi.org/10.3390/idr16050064
Chicago/Turabian Style
Pallotto, Carlo, Andrea Tommasi, Elisabetta Svizzeretto, Giovanni Genga, Giulia Gamboni, Anna Gidari, and Daniela Francisci.
2024. "Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes" Infectious Disease Reports 16, no. 5: 828-835.
https://doi.org/10.3390/idr16050064
APA Style
Pallotto, C., Tommasi, A., Svizzeretto, E., Genga, G., Gamboni, G., Gidari, A., & Francisci, D.
(2024). Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes. Infectious Disease Reports, 16(5), 828-835.
https://doi.org/10.3390/idr16050064